Entasis Therapeutics

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

You can watch ETTX and buy or sell other stocks, options, and ETFs commission-free!

About ETTX

Entasis Therapeutics Holdings, Inc. operates as a clinical stage biopharmaceutical company. It focuses on the discovery and development of novel antibacterial products for serious drug-resistant bacterial infections. 

CEO
Manoussos Perros, PhD
CEOManoussos Perros, PhD
Employees
51
Employees51
Headquarters
Waltham, Massachusetts
HeadquartersWaltham, Massachusetts
Founded
2015
Founded2015
Employees
51
Employees51

ETTX Key Statistics

Market cap
104.80M
Market cap104.80M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
86.16K
Average volume86.16K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$3.88
52 Week high$3.88
52 Week low
$1.40
52 Week low$1.40

ETTX Earnings

-$0.36
-$0.24
-$0.12
$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 3, Pre-Market
ActualExpected Nov 3, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.